miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke
Iranian Journal of Pharmaceutical Research · 15.04.2026 · 25 (1)
DOI: 10.5812/ijpr-167245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 15.04.2026. Verfasst von Nana Hao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xi'an Daxing Hospital, Xi'an, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Ischemic stroke triggers a strong neuroinflammatory response involving cytokines, which are fundamentally involved in tissue damage and repair.
Objectives
The present study was designed to investigate the therapeutic potential of miR-146a-enriched extracellular vesicles derived from bone marrow mesenchymal stem cells (BMSC-EVs) in a rat model of middle cerebral artery occlusion (MCAO). Methods: miR-146a was transfected into BMSCs using Lipofectamine 3000. Extracellular vesicles (EVs) were isolated from transfected BMSCs using ultracentrifugation. Thirty rats were randomly assigned to three groups (n = 10 per group): (1) Control (received FBS), (2) miR-control EVs (miR-NC), and (3) miR-146a-enriched EVs, administered intravenously post-ischemia. Neurological deficits were evaluated with the Bederson score, and cytokine levels, including tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), interleukin (IL)-6, IL-10, as well as transforming growth factor β (TGF-β), were measured in splenocyte culture and brain tissues using enzyme-linked immunoassay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR), respectively. The expression of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1), Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6), and nuclear factor kappa B (NF-κB) was also measured using RT-PCR.
Results
Results showed that EVs enriched in miR-146a significantly decreased pro-inflammatory cytokines, TNF-α, IFN-γ, and IL-6, and increased anti-inflammatory markers, IL-10 and TGF-β, when compared with miR-control EVs and FBS-treated groups. miR-146a-EV-treated rats also displayed better Bederson scores, which reflected better neurological recovery. Results also demonstrated that miR-146a-enriched EVs downregulated IRAK1, TRAF6, and NF-κB signaling in ischemic brain tissue.
Conclusions
These results indicate that miR-146a overexpression in BMSC-EVs can significantly inhibit neuroinflammation and promote functional improvement in ischemic stroke models, supporting its targeted therapeutic potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Xi'an Daxing Hospital, Xi'an, China.
- Department of Neurology, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, China.
Zitieren
APA
Hao, N., & Gong, F. (2026). miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke. Iranian Journal of Pharmaceutical Research, 25(1). https://doi.org/10.5812/ijpr-167245
Vancouver
Hao N, Gong F. miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke. Iranian Journal of Pharmaceutical Research. 2026;25(1). doi:10.5812/ijpr-167245
BibTeX
@article{Hao2026,
author = {Hao, Nana and Gong, FuHua},
title = {miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2026},
volume = {25},
number = {1},
doi = {10.5812/ijpr-167245}
}
EUVIMED